My NCBI Sign In
Jump to: Authorized Access | Attribution | Authorized Requests

Study Description

The Gabriella Miller Kids First Pediatric Research Program (Gabriella Miller Kids First Pediatric Research Program) (Kids First) is a trans-NIH effort initiated in response to the 2014 Gabriella Miller Kids First Research Act and supported by the NIH Common Fund. This program focuses on gene discovery in pediatric cancers and structural birth defects and the development of the Gabriella Miller Kids First Pediatric Data Resource (Kids First Data Resource). Both, childhood cancers and structural birth defects are critical and costly conditions associated with substantial morbidity and mortality. Elucidating the underlying genetic etiology of these diseases has the potential to profoundly improve preventative measures, diagnostics, and therapeutic interventions.

Whole Genome Sequence (WGS) and phenotypic data from this study are accessible through dbGaP and, where other Kids First datasets can also be accessed.

Goals of this ongoing study are to identify novel "congenital cranial dysinnervation disorder" (CCDD) genes and define the role of the wildtype and mutant genes in normal and aberrant development. The umbrella term (CCDD) refers to congenital birth defects with malformation of one or more cranial nerves, typically resulting in limitations of eye and/or face movement. Examples of CCDDs include congenital fibrosis of the extraocular muscles (CFEOM), congenital ptosis, Duane retraction syndrome (DRS), horizontal gaze palsy with progressive scoliosis (HGPPS), congenital 3rd, 4th or 6th nerve palsies, Moebius syndrome (MBS), and hereditary congenital facial paresis (HCFP). In some cases, anosmia, and disorders of hearing, sucking, chewing, swallowing, and breathing may also be classified as CCDDs. CCDDs can be accompanied by additional birth defects such as intellectual and social disabilities, developmental delays, limb anomalies, and cardiac, GI, and GU disorders. The genetic basis of multiple CCDDs has been determined, and the gene mutations typically alter cranial motor neuron identity or function, or perturb axon growth and guidance. Despite these successes, the genetic etiologies of many inherited CCDDs remain unidentified.

Authorized Access
Publicly Available Data (Public ftp)

Connect to the public download site. The site contains release notes and manifests. If available, the site also contains data dictionaries, variable summaries, documents, and truncated analyses.

Study Inclusion/Exclusion Criteria

Individuals are included in the study if they were diagnosed with clinical features suggestive of congenital cranial nerve dysfunction, were appropriately consented and enrolled, donated a biological sample for DNA extraction of sufficient quality and quantity, and provided appropriate clinical data for phenotypic evaluation. Individuals with suspected acquired conditions were excluded.

Molecular Data
TypeSourcePlatformNumber of Oligos/SNPsSNP Batch IdComment
Whole Genome Sequencing Illumina HiSeq X v2.5 N/A N/A Library prep details: KAPA Hyper PCR-free (KK8505, KAPA Biosystems Inc.)
DNA Library Construction KAPA Biosystems Kapa Hyper Library Preparation Kit N/A N/A
Study History

Recruitment of individuals affected by familial CFEOM was initiated in the late 1990s. The study was subsequently expanded to include individuals with other disorders based on cranial nerve and muscle dysfunction, as well as individuals with non-CCDD symptoms that have been observed in syndromic forms of the CCDDs.

Selected publications
Diseases/Traits Related to Study (MESH terms)
Links to Related Resources
Authorized Data Access Requests
Study Attribution